Skip to content

Secretin Research

Peer-reviewed studies from PubMed on Secretin mechanisms, clinical trials, and safety data. 9,135 total studies indexed.

Research Overview

9,135Total studies
1Human trials
0Systematic reviews
1Animal studies
✓ Strong EvidenceEvidence level
20252026Date range
Current obesity reportsPMID: 41575482

The gastrointestinal tract acts as an endocrine organ, releasing hormones that regulate glucose homeostasis, appetite, energy expenditure, and gastrointestinal motility. In type 2 diabetes (T2DM) and obesity, this finely tuned hormonal system is disrupted, contributing to metabolic dysfunction. T...

View on PubMed
The Korean journal of internal medicinePMID: 41531214

Pancreatic juice (PJ) analysis has emerged as a promising modality for the diagnosis of pancreatic diseases, particularly pancreatic ductal adenocarcinoma and chronic pancreatitis. This review explores the role of PJ analysis in identifying biomarkers for the early detection and differentiation o...

View on PubMed
Abdominal radiology (New York)PMID: 41528433

Magnetic resonance imaging (MRI) with secretin stimulation allows non-invasive assessment of pancreatic secretion in vivo. Software (PFTquant) can facilitate quantification of secretory response. Our objective was to quantify secretory response for a clinical sample of pediatric patients and comp...

View on PubMed
American journal of physiology. Gastrointestinal and liver physiologyPMID: 41525767

Serine/threonine phosphatase 1 (PP1) and phosphatase 2A (PP2A) play important roles in mediating cellular signaling in different tissues to different stimuli, including in protein synthesis, growth, cell cycle regulation, and secretion. However, their roles in various pancreatic exocrine function...

View on PubMed
GastroenterologyPMID: 41498716

Endoscopic ultrasound (EUS) has evolved from a diagnostic imaging tool into a versatile platform that enables high-precision access, sampling, and therapy across gastrointestinal and hepatobiliary diseases. This review summarizes recent advances that are reshaping diagnostic practice and theragno...

View on PubMed
International journal of obesity (2005)PMID: 41495448

Few studies have compared gut hormone responses between bariatric procedures. This study compared Roux-en-Y and one-anastomosis gastric bypass (RYGB and OAGB) regarding glucagon-like peptide-1 (GLP-1), secretin, and glucose-insulin dynamics.This study included 41 participants (RYGB: n =&#x...

View on PubMed
Journal of the American College of Radiology : JACRPMID: 41493264

Chronic pancreatitis (CP) is a progressive disorder of the pancreas characterized by irreversible parenchymal and ductal changes, leading to chronic pain and pancreatic insufficiency. Its impact on quality of life can be profound and may further be complicated by acute inflammation superimposed o...

View on PubMed
Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.]PMID: 41469265

Establishing an effective screening method for pancreatic ductal adenocarcinoma (PDAC) is important. This study re-evaluated the diagnostic utility of the duodenal fluid (DF) marker S100 calcium-binding protein P (S100P) during upper gastrointestinal endoscopy (GIE).Study 1 and Study 2 prospectiv...

View on PubMed
PLoS biologyPMID: 41411332

Enteroendocrine cells (EECs) are rare sensory cells in the intestinal epithelium that coordinate digestive physiology by secreting a diverse repertoire of peptide hormones. These hormones are the main effectors of EEC function, and their characterization requires direct observation by mass spectr...

View on PubMed
Clinical radiologyPMID: 41380645

Exocrine pancreatic insufficiency (EPI) can be assessed noninvasively using magnetic resonance cholangiopancreatography (MRCP) with secretin stimulation. This pilot study measured pancreatic volumes in children with suspected EPI and quantified total secreted fluid volume after secretin stimulati...

View on PubMed
Cell reportsPMID: 41348539

Obesity necessitates effective therapeutics targeting energy-regulating pathways. Secretin (SCT) shows therapeutic promise but is limited by its short half-life and lack of potent agonists. We investigated purmorphamine, a small-molecule modulator of the SCT receptor (SCTR), for its ability to en...

View on PubMed
Neurology internationalPMID: 41295444

Autism spectrum disorder (ASD) is a neurodevelopmental disorder typically characterized by impaired social communication. Previous reports have postulated gut microbiota to be an important non-genetic factor affecting ASD-like phenotypes in mice, as germ-free (GF) mice show impaired social commun...

View on PubMed
The Journal of pharmacology and experimental therapeuticsPMID: 41160938

Enteroendocrine cells (EECs) in the gastrointestinal tract play a critical role in sensing dietary fat and regulating the secretion of gut hormone. However, chronic high-fat diet (HFD) intake can lead to maladaptive changes in these cells, impairing hormone regulation. Transient receptor potentia...

View on PubMed
Small (Weinheim an der Bergstrasse, Germany)PMID: 41110147

Dual-constriction nanopores offer a second sensing region that enhances the interactions with analytes at the single-molecule level. However, existing biological nanopore complexes, i.e., CsgG-CsgF, are prone to dissociation upon high voltages, enforcing the development of robust "one-take" platf...

View on PubMed
Nature communicationsPMID: 41102207

The bundle-forming pilus (BFP) system in enteropathogenic Escherichia coli (EPEC) produces type IVb pili that enable bacterial auto-aggregation, facilitating bacterial adhesion, colonization, and virulence. One of its components, lipoprotein BfpB, interacts with BfpG to form a secretin channel co...

View on PubMed
The lancet. Gastroenterology & hepatologyPMID: 41061719

In patients with malignant gastric outlet obstruction, endoscopic ultrasonography-guided gastroenterostomy might be superior to surgical gastroenterostomy, but randomised trials are scarce. We aimed to assess time to resumption of oral intake and the rate of persistent or recurrent obstructive sy...

View on PubMed
GutPMID: 41043862

Dipeptidyl peptidase-4 inhibitors (DPP-4is) have been reported to exhibit therapeutic effects in Parkinson's disease (PD), increasing their potential for drug repurposing. One aspect of PD pathogenesis is thought to be associated with the gut-brain axis, where α-synuclein from the gut is tr...

View on PubMed

Disclaimer: This page aggregates research from PubMed for educational purposes only. Inclusion of a study does not imply endorsement of its findings. Always consult a qualified healthcare professional before making decisions based on research literature.